Horizon Therapeutics Public Ltd Co Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Horizon Therapeutics Public Ltd Co quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 229M shares, a 0.61% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 229M -1.39M -0.61% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 229M -913K -0.4% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 227M -135K -0.06% Dec 31, 2022 10-Q 2023-08-08
Q3 2022 229M +2.05M +0.91% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 230M +4.62M +2.05% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 229M +4.85M +2.16% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 227M +6.04M +2.73% Dec 31, 2021 10-K 2023-03-01
Q3 2021 227M +6.03M +2.73% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 226M +26.1M +13.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 225M +34.1M +17.9% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 221M +33.3M +17.7% Dec 31, 2020 10-K 2022-03-01
Q3 2020 221M +33.8M +18.1% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 200M +13.5M +7.27% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 191M +5.83M +3.16% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 188M +19.2M +11.3% Dec 31, 2019 10-K 2021-02-24
Q3 2019 187M +19.3M +11.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 186M +19.5M +11.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 185M +19.8M +12% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 169M +4.46M +2.71% Dec 31, 2018 10-K 2020-02-26
Q3 2018 168M +3.67M +2.24% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 167M +3.28M +2.01% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 165M +2.35M +1.45% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 164M +2.78M +1.72% Dec 31, 2017 10-K 2019-02-27
Q3 2017 164M +2.62M +1.63% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 163M +2.57M +1.6% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 163M +2.37M +1.48% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 162M +1.94M +1.21% Dec 31, 2016 10-K 2018-02-28
Q3 2016 161M +1.97M +1.24% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 161M +2.39M +1.51% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 160M +27M +20.2% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 160M +35.6M +28.7% Dec 31, 2015 10-K 2017-02-27
Q3 2015 159M +53.5M +50.6% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 158M +84.1M +113% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 133M +61.9M +86.6% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 124M +57.9M +87.7% Dec 31, 2014 10-K 2016-02-29
Q3 2014 106M +39.9M +60.6% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 74.3M +11M +17.3% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 71.4M +9.47M +15.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 66.1M +4.38M +7.09% Dec 31, 2013 10-K/A 2015-03-02
Q3 2013 65.9M +4.82M +7.9% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 63.3M +29.6M +87.6% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 61.9M +28.2M +83.8% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 61.7M +42.1M +214% Dec 31, 2012 10-K 2014-03-13
Q3 2012 61M +41.5M +213% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 33.7M +32.3M +2155% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 33.7M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 19.6M +18.1M +1217% Dec 31, 2011 10-K 2013-03-18
Q3 2011 19.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 1.5M Jun 30, 2011 10-Q 2011-09-02
Q4 2010 1.49M Dec 31, 2010 10-K 2012-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.